Neogen NEOG
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 35th percentile, 5-year average -66.2x
Around its usual level · 54th percentile, 5-year average 1.6x
#1741 of 5330 stocks by PB (1 = cheapest)
Below its usual level · 32nd percentile, 5-year average 3.9x
#3011 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.18 | – | 1.56 | 54% (pricier than usual) | #1741 of 5330 (1 = cheapest) |
| PE | -43.19 | -91.93 | -66.18 | 35% (cheaper than usual) | – |
| PS | 2.77 | 2.81 | 3.91 | 32% (cheaper than usual) | #3011 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on NEOG.
Sign in to join the discussion.